# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
SeaStar announced that the FDA has agreed to the final labeling for QUELIMMUNE, a novel treatment for children with acute kidne...
SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage medical device company developing proprietary solutions to...